KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$29.37
+7.82%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$27.31
From 52W high+0.00%
Volume637262.00
Market cap$1.75B
P/E (TTM)—
P/S (TTM)16.4x
Div yield—
Key dataOct 19, 2026
Open
$27.31
From 52W high
+0.00%
Volume
637262.00
Market cap
$1.75B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.4x
P/E (TTM)
—
RSI (14)
59.6
MomentumView details →
1D Return
+7.82%
YTD Return
+10.29%
SummaryUpdated Jul 1, 2026
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) is a wearable medical device and digital healthcare company founded in 2014 and headquartered in Kirkland, Washington. The company went public in March 2025 and focuses on transforming patient outcomes in cardiovascular disease through innovative monitoring and therapeutic intervention technologies. Kestra specializes in developing connected medical devices that are designed to be intuitive and intelligent, with their primary focus on protecting patients at elevated risk of sudden cardiac arrest.
Similar companies
Latest newsMore news →
Kestra Medical Technologies, Ltd. reported financial results for the first quarter of fiscal year 2027, ended July 31, 2026.35d agoJeffrey Lawrence Schwartz, a Director and 10% Owner of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), sold 3,890 common shares for about $97,942 on September 8, 2026 to cover tax withholding obligations tied to restricted stock unit vesting.39d agoKestra Medical Technologies announced it will report its first quarter fiscal 2027 financial results after market close on September 14, 2026.49d ago